DK0923585T3
(en )
2002-07-01
Phosphinate-based inhibitors of matrix metalloproteinases
DE69905683D1
(en )
2003-04-10
Pyrimidine inhibitors of HIV replication
DK0842945T3
(en )
2003-06-10
Heterocyclic Compounds as Inhibitors of Leukocyte Adhesion and VLA-4 Antagonists
DK0986309T3
(en )
2008-06-09
Use of oil bodies
ID19602A
(en )
1998-07-23
SUBSTITUTED PYRIDINE AS A SELECTIVE INHIBITOR OF CYCLOXIGAGE-2
DE69630221D1
(en )
2003-11-06
STABLE ALCOHOLIC-AQUEOUS COMPOSITION
DK0842944T3
(en )
2003-10-27
Heterocycles as inhibitors of leukocyte adhesion and as antagonists of VLA-4
DK0842943T3
(en )
2003-06-02
5-Ring heterocyclic compounds as inhibitors of leukocyte adhesion and as VLA-4 antagonists
ID22650A
(en )
1999-12-02
USE OF LIPASE LIGHTS INHIBITORS
DK1047450T3
(en )
2003-01-27
Combinations of ACE inhibitors and MMP inhibitors
DK1114641T3
(en )
2006-05-15
Fluoroether Compositions and Methods for Inhibiting Their Degradation in the Presence of a Lewis Acid
NO983957L
(en )
1999-03-01
Method of joining two-phase stainless steel
FI971747A0
(en )
1997-04-23
Computer and method of using a computer
PT927173E
(en )
2002-11-29
DERIVATIVES OF ¬2- (1-PIPERAZINYL) ETOXY | METHYL
DK1045691T3
(en )
2005-03-14
Combinations of statin carboxyl alkyl ether
NO983666L
(en )
1998-12-17
Crystal modification of a pharmaceutical surfactant
IT1298159B1
(en )
1999-12-20
DERIVATIVES OF A 5-AROYLNAPHTHALENE
IS5223A
(en )
1999-10-19
Pharmaceutical formulations of tizoxanide and nitazoxanide
DK0895782T3
(en )
2005-01-03
Pharmaceuticals of cilansetron stabilized against racemization
DK0861070T3
(en )
2000-07-31
Use of NADPH Oxidase Inhibitors to Prepare a Drug to Prevent Atherosclerosis
DK1066276T3
(en )
2003-10-06
Method of synthesis of HIV protease inhibitor
DK0864564T3
(en )
2002-09-23
Particular method for the preparation of alpha-bromolactam derivatives
DK0951561T3
(en )
2001-10-08
Enzymatic Methods for Preparation of (S) Cyanhydrines
FI974533L
(en )
1999-06-17
Preprocessing of events to generate a report
DK0998290T3
(en )
2005-01-03
Use of vitamin D compounds to prevent graft rejection